Genalta is an innovative biotechnology company established in 2004 by individuals who share the passion to ride the future of genomic research. Our mission is to become the leader, in Italy and Europe, in the pathologic aging prevention and nutrigenomics

Investing in Scientific Infrastructure
Genalta is investing in structures and applications to work out the most advanced scientific know-how to prevent, slow or invert pathologic aging processes, thus offering immediate benefits to the people and to society.

Aging Prevention
SNPs is the key word in the pathologic aging prevention. The SNPs (Single Nucleotide Polymorphisms) are individual differences in gene sequences. Some of these are linked to the risk of disorders and of pathologic aging. The SNPs analysis performed by Genalta allows to rationally structure customized preventive treatments with the aim to extend life and improve its quality.

Nutrigenomics
Genalta operates also in the field of nutrigenomics research. The identification and understanding of individual differences in gene expression in response to diet can lead to food products and supplements customized for an individual’s nutritional needs.